{"abstract": "A unit of the Swiss drug maker Roche is acquiring the biotechnology firm based in San Diego, Calif., that was spun off from Aragon Pharmaceuticals last year.", "web_url": "https://dealbook.nytimes.com/2014/07/02/roche-to-pay-up-to-1-7-billion-for-seragon-pharmaceuticals/", "snippet": "A unit of the Swiss drug maker Roche is acquiring the biotechnology firm based in San Diego, Calif., that was spun off from Aragon Pharmaceuticals last year.", "lead_paragraph": "LONDON \u2013 The Swiss drug maker Roche Group said on Wednesday that it would pay up to $1.7 billion to acquire Seragon Pharmaceuticals, a privately held biotechnology firm focused on developing treatments for breast cancer.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/03/business/international/03roche/03roche-articleLarge.jpg", "height": 391, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/07/03/business/international/03roche/03roche-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 391}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/03/business/international/03roche/03roche-jumbo.jpg", "height": 667, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/03/business/international/03roche/03roche-superJumbo.jpg", "height": 1334, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/03/business/international/03roche/03roche-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/07/03/business/international/03roche/03roche-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/03/business/international/03roche/03roche-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Roche to Pay Up to $1.7 Billion for Seragon Pharmaceuticals", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Biotechnology", "rank": 1, "major": "N"}, {"name": "subject", "value": "Clinical Trials", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 4, "major": "N"}, {"name": "persons", "value": "Scheller, Richard H", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Genentech Inc", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Roche Holding A G", "rank": 8, "major": "N"}, {"name": "glocations", "value": "Basel (Switzerland)", "rank": 9, "major": "N"}, {"name": "glocations", "value": "San Diego (Calif)", "rank": 10, "major": "N"}, {"name": "glocations", "value": "San Francisco (Calif)", "rank": 11, "major": "N"}], "pub_date": "2014-07-02T08:15:51+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Chad Bray", "person": [{"firstname": "Chad", "middlename": null, "lastname": "Bray", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/234002a3-2cbc-5def-a872-149f263255d4", "word_count": 301, "uri": "nyt://article/234002a3-2cbc-5def-a872-149f263255d4"}